Condition

Fallopian Tube Carcinoma clinical trials and research

• 12Clinical trials
• 7Countries

Newest Fallopian Tube Carcinoma clinical trials

All recruiting trials (12)

• Dual-target CAR-NK Cells for Peritoneal Cancers of the Ovary, Fallopian Tube, or Pseudoperitoneal Disease

  This trial tests a dual-target CAR-NK cell therapy for people with recurrent or hard-to-treat epithelial ovarian, fallopian tube, or primary peritoneal cancer who express two or more specific tumor markers.

  Recruiting Phase 1/2 Beijing Biotech · Shenzhen, Guangdong · NCT07617753

• IGFBP-2 vaccine after platinum to slow ovarian cancer recurrence

  This study tests whether giving an IGFBP-2 vaccine after one carboplatin dose can help prevent progression of ovarian, fallopian tube, or primary peritoneal cancer that has shown serologic recurrence.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07495124

• Dual-target CAR-NK therapy for recurrent ovarian, fallopian tube, or primary peritoneal cancer

  This trial tests whether dual-target CAR‑NK cells can shrink tumors in people with recurrent or refractory epithelial ovarian, fallopian tube, or primary peritoneal cancer whose tumors express at least two of MSLN, FRα, or MUC16.

  Recruiting Phase 1/2 Beijing Biotech · Shenzhen, Guangdong · NCT07480954

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Reducing fatigue in adults with ovarian cancer on PARP inhibitors

  This study is testing a tele-health program called REVITALIZE to see if it can help reduce fatigue and improve daily life for adults with ovarian cancer who are taking PARP inhibitors.

  Recruiting at 6 sites Dana-Farber Cancer Institute · Aurora, Colorado and 5 other locations · NCT06710548

• Using cryocompression and cilostazol to prevent nerve damage from chemotherapy in women with gynecological cancers

  This study is testing if using cryocompression therapy alone or with a medication called cilostazol can help prevent nerve damage from chemotherapy in women with gynecological cancers.

  Recruiting Phase 2 Emory University · Atlanta, Georgia and 2 other locations · NCT06492070

• Treatment for recurrent ovarian cancer with HER2 expression

  This study is testing a new combination of treatments for women with recurrent ovarian cancer that has a specific protein called HER2 to see if it helps them feel better and live longer.

  Recruiting Phase 2 Peking University Cancer Hospital & Institute · Beijing, Beijing Municipality · NCT06420973

• Using blood volume management during surgery for ovarian cancer patients

  This study tests if a blood management technique called acute normovolemic hemodilution can help women with advanced ovarian cancer during surgery by reducing the need for blood transfusions and improving safety.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06290193

• Observing cancer recurrence using a blood test

  This study is testing a new blood test to see if it can help find out if cancer comes back in people who have been treated for early-stage solid tumors.

  Recruiting at 49 sites Guardant Health, Inc. · Birmingham, Alabama and 56 other locations · NCT05059444

• Maintenance therapy for ovarian cancer after chemotherapy

  This study is testing a new treatment called DCVAC/OvCa to see if it can help women with advanced ovarian cancer feel better after their initial chemotherapy.

  Recruiting Phase 2 Peking University Third Hospital · Beijing, Beijing Municipality · NCT04834544

• Imaging with a new radioactive tracer for solid tumors

  This study is testing a new imaging method using a special radioactive tracer to see if it can help find tumor cells in patients with solid tumors like ovarian and breast cancers, while also looking at how safe it is and how it relates to certain genetic factors.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT03604315

• Study of women with BRCA1 or BRCA2 gene variants and cancer risk

  This study looks at Japanese women with BRCA1 or BRCA2 gene changes to see how likely they are to develop certain cancers and whether a specific surgery can help prevent them.

  Recruiting Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan · Okayama · NCT03296826

Related topics

Quick answers

How many Fallopian Tube Carcinoma clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (7 trials), China (4 trials), France (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →